Sargent Investment Group, LLC Cytosorbents Corp Transaction History
Sargent Investment Group, LLC
- $483 Million
- Q2 2024
A detailed history of Sargent Investment Group, LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Sargent Investment Group, LLC holds 1,433,500 shares of CTSO stock, worth $1.45 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
1,433,500
Previous 1,366,319
4.92%
Holding current value
$1.45 Million
Previous $1.3 Million
22.73%
% of portfolio
0.21%
Previous 0.29%
Shares
24 transactions
Others Institutions Holding CTSO
# of Institutions
57Shares Held
16.9MCall Options Held
10.1KPut Options Held
500-
Avenir Corp Washington, DC2.97MShares$3 Million0.21% of portfolio
-
Skylands Capital, LLC2.84MShares$2.87 Million0.3% of portfolio
-
Granahan Investment Management, LLC Waltham, MA2.66MShares$2.69 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.97 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.54MShares$1.55 Million0.0% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $44M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...